Any current/future new fundraising through debt or equity?

There is no explicit mention of any immediate or planned new fundraising through debt or equity in the provided pages. The company has recently made a backward integration announcement involving investment in a CPVC resin plant with a total CAPEX around Rs. 150 crores, with 20% funded by a technical partner. Management indicated that after a heavy CAPEX cycle in the last three years (~Rs. 1,500 crores), the CAPEX would be on hold for the next 2-3 years except for maintenance. Cash flows from existing and new businesses (adhesives, bathware, paint) are expected to generate sufficient internal r

Any current/future capex/capital investment/strategic investment?

Astral has invested around Rs. 1,500 crores in CAPEX over the last three years, impacting ROE due to market conditions. This year’s CAPEX guidance is around Rs. 300 crores, with Rs. 50 crores expected in Q1. Additional Rs. 120 crores CAPEX is planned for a backward integration CPVC resin plant, spread over 12 months. After this year, CAPEX for the pipe division will largely be maintenance-driven, with no major expansions planned for 2-3 years. The CPVC plant (40,000 tons capacity) will serve 100% captive use initially; future capacity may increase as demand grows. Plans to stop major CAPEX cyc

Future growth expectations in sales/revenue/volumes?

Astral expects a minimum double-digit volume growth over the next five years, with potential for higher growth due to upcoming backward integration (Page 29). The new CPVC resin manufacturing plant (40,000 tons capacity) is expected to be operational by Q2 FY '27, which will improve margins and production stability (Pages 15, 24, 29). New businesses like Bathware and Paints have low current market share but are expected to grow faster than established segments, with Paints targeting a minimum 20% growth by year-end (Pages 24, 29). The piping division grew 30% year-on-year in July, and su

Future growth expectations in earnings/operating earnings/profits/EPS?

Astral expects a minimum double-digit volume growth over the next five years, possibly higher with the upcoming backward integration plant. New businesses like Bathware are anticipated to grow faster than established ones, contributing significantly to top-line growth. Despite recent polymer price challenges, Astral foresees double-digit growth as achievable, supported by market recovery and new capacity coming online in the second half of next year. EBITDA margins are expected to be maintained or improved, with the piping business aiming for 16-18% annual EBITDA margins. The CPVC plan

IN US

Sale is live|00:00:00left today

Astral LtdQ2 FY25Industrial Products

Astral Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,487P/E: 80.9Market Cap: ₹41.7K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Astral expects a minimum double-digit volume growth over the next five years, with potential for higher growth due to upcoming backward integration (Page 29).
→The new CPVC resin manufacturing plant (40,000 tons capacity) is expected to be operational by Q2 FY '27, which will improve margins and production stability (Pages 15, 24, 29).
→New businesses like Bathware and Paints have low current market share but are expected to grow faster than established segments, with Paints targeting a minimum 20% growth by year-end (Pages 24, 29).
→The piping division grew 30% year-on-year in July, and sustainable double-digit growth is expected despite recent polymer price challenges (Pages 16, 29).
→If favorable policies like anti-dumping duties and BIS certifications materialize, volume growth could exceed 15% (Page 28).
→The management emphasizes long-term growth focus, willing to trade slight margin reductions for volume gains when justified (Pages 16, 29).

Margin guidance

Category 3

→Astral expects a minimum double-digit volume growth over the next five years, possibly higher with the upcoming backward integration plant.
→New businesses like Bathware are anticipated to grow faster than established ones, contributing significantly to top-line growth.
→Despite recent polymer price challenges, Astral foresees double-digit growth as achievable, supported by market recovery and new capacity coming online in the second half of next year.
→EBITDA margins are expected to be maintained or improved, with the piping business aiming for 16-18% annual EBITDA margins.
→The CPVC plant with 40,000-ton capacity is anticipated to enhance margins and volume, starting commercial production by Q2 FY '27.
→Improvements in EBITDA and operating efficiency expected as CAPEX cycle concludes within two to three years, driving better ROI and ROC.
→With factors like anti-dumping duties (ADD) and government spending potentially favorable, growth could reach 15% or more.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no explicit mention of any immediate or planned new fundraising through debt or equity in the provided pages.
→The company has recently made a backward integration announcement involving investment in a CPVC resin plant with a total CAPEX around Rs. 150 crores, with 20% funded by a technical partner.
→Management indicated that after a heavy CAPEX cycle in the last three years (~Rs. 1,500 crores), the CAPEX would be on hold for the next 2-3 years except for maintenance.
→Cash flows from existing and new businesses (adhesives, bathware, paint) are expected to generate sufficient internal resources for growth.
→Any future acquisition or investment opportunities will be evaluated but currently, nothing specific is indicated regarding additional fundraising.
→The focus is on organic growth and efficient utilization of past CAPEX rather than raising new funds in near term.

Order book

- The call transcript does not explicitly mention the current or expected order book or pending orders in numeric terms. - However, positive pointers indicate an improving demand outlook: - Volume started picking up from July onwards after a flat Q1. - PVC anti-dumping duty expected this quarter is anticipated to aid volume and value growth. - Government spending on OPVC lines is expected to restart, leading to good orders. - Upcoming Kanpur plant (ready in Q3) will support growth in North markets (UP, Bihar, NCR). - Demand revival is expected between the third week of August and Diwali due to home improvement activities. - Industry challenges persist, but good prospects are expected in the near future. - Management is committed to growth and expects double-digit volume growth for FY '26. In summary, while specific orderbook numbers are not disclosed, management expresses optimism on improving order inflows and demand.

Capex plans

Yes

→Astral has invested around Rs. 1,500 crores in CAPEX over the last three years, impacting ROE due to market conditions.
→This year’s CAPEX guidance is around Rs. 300 crores, with Rs. 50 crores expected in Q1.
→Additional Rs. 120 crores CAPEX is planned for a backward integration CPVC resin plant, spread over 12 months.
→After this year, CAPEX for the pipe division will largely be maintenance-driven, with no major expansions planned for 2-3 years.
→The CPVC plant (40,000 tons capacity) will serve 100% captive use initially; future capacity may increase as demand grows.
→Plans to stop major CAPEX cycles soon to improve capital efficiency, with operational utilization expected to enhance returns.
→Astral is open to future acquisitions/opportunities to fuel growth, but no immediate surprise items on the cards.

How does Astral Ltd rank vs peers in Industrial Products?

Pro feature

1Astral Ltd

Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like Astral Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio